Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Novartis
MacroGenics
Nurix Therapeutics, Inc.
Guardant Health, Inc.
Xencor, Inc.
858 Therapeutics, Inc.
Toray Industries, Inc
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Klus Pharma Inc.
Theratechnologies
Pfizer
Cybrexa Therapeutics
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
Hoffmann-La Roche
Eli Lilly and Company
Instil Bio
Xencor, Inc.
MacroGenics
Gilead Sciences
Novartis
Pfizer
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Valerio Therapeutics
INSYS Therapeutics Inc